Certified by Founder
Lodge
Biotia
start up
United States
- New York, New York
- 24/08/2022
- Series A
- $8,000,000
Biotia is a health tech company spun out of Cornell Tech leveraging next-generation sequencing and artificial intelligence for rapid precision infectious disease discovery. Our software and laboratory technology enable clinicians and researchers to guide patient treatment and improve health outcomes.
- Industry Biotechnology Research
- Website https://www.biotia.io/
- LinkedIn https://www.linkedin.com/company/biotia/
Related People
Niamh B. O'HaraCo Founder
United States -
New York, New York,
CEO and co-founder of Biotia, a startup working with hospitals and researchers to leverage high-complexity tests and artificial intelligence for rapid precision infectious disease discovery to guide patient treatment and improve health outcomes.
DISA Technologies, Inc. | $33,000,000 | (May 1, 2026)
Jupid | $840,000 | (May 1, 2026)
Dreambase | $3,700,000 | (May 1, 2026)
Creati AI | $20,000,000 | (May 1, 2026)
Manifest OS | $60,000,000 | (May 1, 2026)
Iterative Health | $77,000,000 | (May 1, 2026)
Blomma | $5,000,000 | (May 1, 2026)
Illuminant Surgical | $8,400,000 | (May 1, 2026)
BioOrbit | $13,334,811 | (May 1, 2026)
Parallel Web Systems | $100,000,000 | (Apr 30, 2026)
Fence | $20,000,000 | (Apr 30, 2026)
Certifyde | $2,000,000 | (Apr 30, 2026)